U.S. Court of Appeals for the Federal Circuit, 2021

Mati Therapeutics, Inc. v. Ocular Therapeutix, Inc.

Mati Therapeutics, Inc. v. Ocular Therapeutix, Inc.
U.S. Court of Appeals for the Federal Circuit · Decided November 8, 2021

Mati Therapeutics, Inc. v. Ocular Therapeutix, Inc.

Opinion

Case: 20-2176 Document: 45 Page: 1 Filed: 11/08/2021

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ MATI THERAPEUTICS, INC., Appellant v. OCULAR THERAPEUTIX, INC., Appellee ______________________ 2020-2176 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2019- 00448. ______________________ JUDGMENT ______________________ HENRY HUANG, White & Case LLP, Palo Alto, CA, ar- gued for appellant. Also represented by HALLIE ELIZABETH KIERNAN, YANG XU; DAVID TENNANT, Washington, DC; ANITA VARMA, Boston, MA.

JENNIFER L. SWIZE, Jones Day, Washington, DC, ar- gued for appellee. Also represented by GREGORY A.

CASTANIAS, AMELIA A. DEGORY; JOHN JOSEPH NORMILE, JR., New York, NY. ______________________ Case: 20-2176 Document: 45 Page: 2 Filed: 11/08/2021

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (LOURIE, O’MALLEY, and STOLL, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

November 8, 2021 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.